title: Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency.
abstract: Increased cardiovascular mortality in adult growth hormone deficiency (GHD) may be, in part, explained by the dyslipidaemia associated with this condition. It is possible that abnormalities of very low density lipoprotein apolipoprotein B-100 (VLDL apoB) metabolism contribute to this dyslipidaemia. To test this hypothesis, we measured VLDL apoB kinetics in adult GH deficient patients (4 females, 3 males; age 50.1 +/- 4.7 yr (mean +/- SEM); BMI 28.2 +/- 1.1 kg/m2; total cholesterol (TC) 6.6 +/- 0.3 mmol/l; triglyceride (TG) 2.8 +/- 0.6 mmol/l; HDL cholesterol 1.1 +/- 0.1 mmol/l) and in control subjects (4 females, 3 male; age 47.0 +/- 4.7 yr; BMI 27.0 +/- 2.6 kg/m2; TC 5.0 +/- 0.4 mmol/l; TG 0.9 +/- 0.2 mmol/l; HDL cholesterol 1.4 +/- 0.1 mmol/l). [1-(13)C] leucine was administered by a primed (1 mg/kg), constant intravenous infusion (1 mg/kg/hr) and VLDL apoB enrichment with 13C leucine was determined using gas-chromatography mass-spectrometry. The GHD patients had a significantly higher hepatic secretion rate of VLDL apoB (15.5 +/- 1.8 mg/kg/day vs 9.4 +/- 0.6 mg/kg/day p = 0.007) and reduced catabolism ofVLDL apoB (metabolic clearance rate; 12.3 +/- 1.7 ml/min vs 24.3 +/- 4.8 ml/min p < 0.05) compared with control subjects. These findings suggest that GH is integrally involved in the regulation of VLDL apoB metabolism.
authors.affiliation: Department of Medicine, UMDS, St. Thomas' Hospital, London, England.
authors.forename: M H
authors.initials: MH
authors.lastname: Cummings
authors.forename: E
authors.initials: E
authors.lastname: Christ
authors.forename: A M
authors.initials: AM
authors.lastname: Umpleby
authors.forename: E
authors.initials: E
authors.lastname: Albany
authors.forename: A
authors.initials: A
authors.lastname: Wierzbicki
authors.forename: P J
authors.initials: PJ
authors.lastname: Lumb
authors.forename: P H
authors.initials: PH
authors.lastname: Sönksen
authors.forename: D L
authors.initials: DL
authors.lastname: Russell-Jones
mesh_terms: D000328:Adult; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000097:blood*; D001057:Apolipoproteins E / Q000235:genetics; D005260:Female; D019382:Human Growth Hormone / Q000172:deficiency*; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology*; D008077:Lipoproteins, LDL / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008798:Mevalonic Acid / Q000097:blood; D008875:Middle Aged; D010641:Phenotype
chemical_list: D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D001057:Apolipoproteins E; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D019382:Human Growth Hormone; D008798:Mevalonic Acid